RecruitingNCT03039309
Endoscopic Submucosal Dissection for Early GI Neoplasia in the United Kingdom
Endoscopic Submucosal Dissection in the Treatment of Early Gastrointestinal Neoplasia: A UK Cohort Study to Assess Effectiveness and Safety
Sponsor
Portsmouth Hospitals NHS Trust
Enrollment
500 participants
Start Date
Aug 5, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
Multicentre cohort study on the use of endoscopic submucosal dissection for the treatment of early gastrointestinal neoplasia.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Male or Female, aged 18 years or above undergoing endoscopic submucosal dissection
- Participant is able to give informed consent for participation in the study
Exclusion Criteria2
- Patients under the age of 18
- Patients unable to give informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREEndoscopic Submucosal Dissection
Endoscopic submucosal dissection is an endoscopic resection technique that utilises an endoscopic knife to remove lesions within the gastrointestinal tract in an en bloc fashion.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03039309
Related Trials
Novel Bipolar Radiofrequency Ablation Knife in Esophageal Lesions
NCT064766781 location
Early Feeding Versus Delayed Feeding After Colorectal Endoscopic Submucosal Dissection
NCT068051235 locations
Endoscopic Resection of Gastrointestinal Neoplasms
NCT047802561 location
Multi-center Evaluation of the Clinical Utility of ESD in the Western Population
NCT029898183 locations
Safety and Efficacy of Traction Robot-assisted Endoscopic Submucosal Dissection for Early Gastric Cancer
NCT067483521 location